SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (1167)6/12/1997 12:05:00 PM
From: Pseudo Biologist   of 9719
 
Andrew, there is yet another NHL drug in advanced clinicals. It is called lym-1 or Oncolym and it is being developed by a small outfit out of Southern Cal named Techniclone (TCLN). This one is also a mouse monoclonal conjugated with a radioisotope. I am told by the TCLN fans that IDEC's and CLTR's drugs are being (have been) tested for low-grade NHL (this matches IDEC's 10K and CLTR's press releases), while Lym-1 is targetting primarily intermediate- and high-grade NHL (they have a nice web page with all sorts of antibody pictures and general explanations of MAb technology techniclone.com ). I posted some stuff in the TCLN thread a few days ago and there are a couple of interesting follow-up posts. I am still trying to figure out the market sizes for the different types of NHL.

If you check the TCLN thread you'll notice that quite a soap opera has been going on for some time. I think the company is legit but the trading of its stock may not have been totally kosher (just gut feeling, no hard facts). I don't have shares on any of these puppies; Ligand, Sequana, Isis, and a few others look so much better to me anyway. And thanks for the nice comments on the Isis thread.

PB (the poster formerly known as Max B)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News